Cold Plasma Market to Reach $5.1 billion by 2032

Cold plasma technologies are transitioning from niche treatment tools to core productivity assets across manufacturing and healthcare. Their ability to improve yields, cut operating costs, and integrate with existing production lines is redefining surface treatment economics and reshaping capital allocation decisions.